Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: Second analysis of a randomised EORTC Melanoma Group trial comparing interferon-α2a (IFNα) and interleukin 2 (IL-2) with or without cisplatin

  • U. Keilholz
  • , P. Martus
  • , C. J.A. Punt
  • , W. Kruit
  • , G. Mooser
  • , D. Schadendorf
  • , D. Liénard
  • , R. Dummer
  • , J. Koller
  • , C. Voit
  • , A. M.M. Eggermont

Research output: Contribution to journal › Article › peer-review

50 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: Second analysis of a randomised EORTC Melanoma Group trial comparing interferon-α2a (IFNα) and interleukin 2 (IL-2) with or without cisplatin'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Immunology and Microbiology

Neuroscience